Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 551 - 600 out of 101,976

Document Document Title
WO/2018/013821A1
The present invention relates to the field of molecular biology and cell biology. More specifically, the present invention relates to a CRISPR-Cas system for a Labyrinthulomycetes host cell.  
WO/2018/012994A9
The invention relates to medicinal microbiology and pharmacology, and relates to a preparation exhibiting an immunostimulatory effect, which may be used for the prevention and treatment of oncological diseases. The essence of the inventi...  
WO/2018/012426A1
Provided is a method for efficiently producing mucic acid from a commonly used organic raw material such as glucose or galactose. Provided is a method for producing mucic acid in which glucose or galactose is used as a starting material ...  
WO/2018/014004A1
A method of forming fungal materials and fungal objects from those fungal materials, the method comprising the steps of growing a first fungal tissue in contact with a nutritive vehicle; supplying a porous material in contact with said f...  
WO/2018/012164A1
[Problem] The purpose of the present invention is to provide: lactic acid bacteria that has a high capacity to promote hyaluronic acid production, that belongs to the Lactobacillus genus, and that is suitable for use in food and beverage...  
WO/2018/013606A1
A polymer or other substrate optimized for growing cells, which takes the form of a micro-thin bag with gas permeable sides. Sides of the bag can be held at a fixed distance from one another with a multitude of tiny micropillars or other...  
WO/2018/013548A1
This invention describes vaccine compositions and their methods of use utilizing inactivated ƒbp1Δ deletion mutant fungal cells.  
WO/2018/013791A1
An ethanologen for producing biofuel from one or more carbohydrates and reducing lactate and acetate production in a biofuel manufacturing process. The ethanologen is made by introducing into the ethanologen one or more exogenous genes r...  
WO/2018/013701A1
The present application relates to recombinant microorganisms expressing a dehydratase useful in a one-step, direct fermentative production of one or more primary alkenes from one or more saturated primary or secondary alcohols. Known, w...  
WO/2018/012941A3
The present application relates to a Leuconostoc mesenteroides CJLM119 strain (KCTC 13043BP) producing a reduced amount of gas, a fermentation starter composition comprising same, and a kimchi production method using said strain.  
WO/2018/011161A1
The present invention relates to a recombinant host cell which is capable of producing a dicarboxylic acid and which comprises a mutant malate dehydrogenase resulting in an increased production of the dicarboxylic acid. The invention als...  
WO/2018/010698A1
Provided are a bacterium, an obtaining method therefor, and applications thereof. The bacterium has the characteristic of co-production of 1,3-propanediol and D-lactic acid. Further, the bacterium is Klebsiella oxytoca, comprising Klebsi...  
WO/2018/012943A1
The present application relates to a Leuconostoc mesenteroides CJLM627 strain (KCTC 13044BP) producing a reduced amount of gas, a fermentation starter composition comprising same, and a kimchi production method using said strain.  
WO/2018/012834A1
The present invention relates to an Akkermansia muciniphila strain having an effect of preventing or treating degenerative brain or metabolic diseases and a use thereof. The intestinal microorganism, Akkermansia muciniphila strain, of th...  
WO/2018/009869A1
Provided herein are genetically engineered cells containing one or more modulated metabolic genes, where the expression of the modulated metabolic gene(s) can be greater than that of an unmodified control. Also provided herein are method...  
WO/2018/006939A1
The present invention refers to aninactivated isolated microorganism belonging to the Mycobacterium tuberculosis complex that comprises the deletion or previous disruption of the phoP gene; and a second gene to prevent DIM production. Al...  
WO/2018/009809A1
Compositions, methods and kits are provided. The compositions, methods and kits are for assembly of series of DNA segments in yeast using homologous recombination. The assembled DNA segments are maintained episomally. Yeast made using th...  
WO/2018/009703A1
Disclosed herein are methods and kits for identifying a subject as having breast cancer. Also provided herein are methods and kits for determining the prognosis of a subject having breast cancer and for determining the progression of bre...  
WO/2018/009372A1
The present disclosure provides novel bacterial strains with altered expression or start codon modification of one or more RNA degradation/processing genes. The RNA degradation genes of the present disclosure are controlled by heterologo...  
WO/2018/009335A1
We found that bacterial spores could be pretreated or initially treated with a partial complement of germinants (i.e., less germinants than would cause germination) and, subsequently, could be treated with the remaining germinants to cau...  
WO/2018/009863A1
Provided are compositions and methods for making a diploid yeast having heterozygosity for at least one chromosome. The method includes mating haploid yeast having at least a first modified chromosome comprising a synthetic chromosome su...  
WO/2018/008786A1
The present invention relates to a Thermococcus onnurineus 480T (deposit number: KCTC13046BP) strain, and a hydrogen producing method comprising: a step (a) of supplying carbon monoxide to the strain in claim 1 and culturing the same; an...  
WO/2018/003858A1
A cell enclosure device according to the present invention is a cell enclosure device for constructing a multicellular structure obtained by culturing cells, a porous membrane being provided to at least a portion of the cell enclosure de...  
WO/2018/005806A2
The present disclosure relates to biosynthetic pathways for producing flavor and fragrance chemicals, such as green notes including trans-2-unsaturated aldehydes and lactones. The present disclosure provides methods for producing trans-2...  
WO/2018/004224A3
The present invention relates to an Epidermidibacterium gen. strain, which belongs to Sporichthyaceae, a culture medium thereof, or a composition containing the same for improving a skin condition or for preventing or treating an inflamm...  
WO/2018/002059A9
The invention relates to a microalga which is genetically modified by inhibiting the Δ0 elongase (Δ0-ELO) enzyme activity, using palmitic acid, a saturated fatty acid, as a substrate, and which is associated with the production of mono...  
WO/2018/005493A2
Disclosed herein are engineered bacteria that manufacture biofilms from bacterial amyloid structures known as curli fibers. These biofilms and biofilm matrices are capable immobilizing enzymes and generating catalytic surfaces.  
WO/2018/004014A1
The invention provides an active microbial transglutaminase (MTG) that does not require protease treatment in a protein expression system using a universal host such as Escherichia coli, that is, an MTG mutant having transglutaminase act...  
WO/2018/005934A1
Methods and compositions are provided for conversion of gaseous alkenes to liquid diols via biological or enzymatic means.  
WO/2018/002270A1
The present invention relates to the field of native outer membrane vesicles (n OMVs), particularly n OMVs having increased levels of lipoproteins on their surface and use of same in immunogenic compositions.  
WO/2018/004224A2
The present invention relates to an Epidermidibacterium gen. strain, which belongs to Sporichthyaceae, a culture medium thereof, or a composition containing the same for improving a skin condition or for preventing or treating an inflamm...  
WO/2018/004016A1
Provided are: a Pseudozyma churashimaensis RGJ1 strain, which is isolated from a pepper plant body and induces induced systemic resistance to plant body pathogens or plant viruses; a microbial preparation for controlling plant diseases o...  
WO/2018/000089A1
Polynucleotides and polypeptides useful in the manufacture of a class of chemical compounds known as alkaloids are provided. The polynucleotides and polypeptides may be used to synthesize alkaloids, including reticuline, thebaine and mor...  
WO/2018/002059A1
The invention relates to a microalga which is genetically modified by inhibiting the Δ0 elongase (Δ0-ELO) enzyme activity, using palmitic acid, a saturated fatty acid, as a substrate, and which is associated with the production of mono...  
WO/2018/006104A1
The invention relates to a biological composition that stimulates Aquilaria spp. to induce agarwood. This inoculant contains 50% prepared by the fungal strain Collectotrichum sp. (TH1) and 50% prepared by the bacterial strain Pseudomonas...  
WO/2018/005770A3
The present disclosure relates to methods for more efficiently recycling reduced electron carriers in a hydrogen-oxidizing microorganism with an operable Calvin-Benson cycle; synthetic carbon fixation pathways that recycle reduced electr...  
WO/2018/004010A1
In order to provide a device for thawing preserved vitrified germ cells and a thawing method that simultaneously realize a high conception rate and facilitate transplantation work, the device for thawing (1) is equipped with a mounting d...  
WO/2018/002581A1
A method of reducing the level of RNA in a biomass comprising filamentous fungus involves the following steps: (i) heating the biomass, downstream of the fermenter to a first temperature in the range 40- 69°C; (ii) heating the biomass t...  
WO/2018/002520A1
Use of a selenised compound for increasing the ethanol content of a composition, said process comprising at least one step for the alcoholic fermentation of said composition carried out in the presence of said selenised compound in a con...  
WO/2018/002248A1
The present invention relates to the field of preservation of microorganisms, and in particular provides a 2-compartment system comprising a first compartment comprising microcapsules with microorganisms in a non-aqueous composition in t...  
WO/2018/004586A1
The present invention discloses the use of probiotics for therapeutic management of major depressive disorder (MDD). Specifically, the invention discloses the method of therapeutically managing MDD in mammals with Irritable bowel syndrom...  
WO/2018/000043A1
The present invention relates to a cell coated with a layer of crystalline Metal Organic Framework (MOF).  
WO/2018/003641A1
Provided is an improvement in C4 dicarboxylic acid productivity in a host cell. A polypeptide that comprises the amino acid sequence represented by SEQ ID NO:2 or an amino acid sequence having 90% or more sequence identity to the aforesa...  
WO/2018/005604A1
The present invention provides a method for inhibiting the growth of food-borne pathogens, nosocomial pathogens and spoilage microorganisms, the method comprising the steps of: contacting at least one lactic acid bacterium strain selecte...  
WO/2018/005655A2
The present disclosure describes methods for generating microbial strains expressing a heterologous bacterial hemoglobin gene that produce biomolecules of interest. In aspects, the disclosure provides novel bacterial strains, which expre...  
WO/2018/002579A1
A method of reducing the level of RNA in a biomass comprising filamentous fungus involves the following steps: (i)heating the biomass, downstream of the fermenter to a first temperature in the range 40- 69°C; (ii)heating the biomass to ...  
WO/2018/002331A1
Provided herein is a composition comprising: a) about 25% up to about 75% of a plasmolysed micro-organism by weight of the total weight of the composition; b) about at least greater than 20% up to about 60% by weight flavor or fragrance,...  
WO/2018/005599A3
The present invention provides a method for inhibiting the growth of pathogens in an animal feed comprising the steps of: contacting an animal feed with at least one lactic acid bacterium strain selected from the group consisting of Lact...  
WO/2017/223501A1
Methods for spray drying gram negative bacteria are provided. Such spray drying methods are performed under conditions that allow for the spray dried composition to retain the biological activity of interest of the gram-negative bacteria...  
WO/2017/223273A1
In certain aspects, described herein are methods, bacteria, and compositions for the reduction of the amount, activity and/or proliferation of colonic group 3 innate lymphoid cells (ILC3s) and for the treatment and/or prevention of disea...  

Matches 551 - 600 out of 101,976